「president」の検索結果
24件：16～20件目を表示
もしかして
-
ent of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that it has started Phase III c...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
ent of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug designatio...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf -
channel subfamily V member 1 Inhibition Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is pleased to announce that “Avarept® Ophthalmic ...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
channel subfamily V member 1 Inhibition Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is pleased to announce that “Avarept® Ophthalmic ...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
vel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a compound (development code: SJP-0...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf